ARCHIVES

Prostate Cancer Prevention Trial Begins At 222 U.S. Sites

This article is from The Cancer Letter archive.

Vol. 19 No. 41 | October 22, 1993

Download PDF Visit The Full Archive

Related Articles

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

April 15, 1994

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

Meta-Analysis Of Randomized Trials Shows Aspirin Reduces Colon Polyp Recurrence

February 27, 2009

Funding Opportunities

November 15, 2002

DCT Board Okays Kaposi Study, Blocks Monitoring Plan

February 26, 1982